NANOCELLECT BIOMEDICAL, INC.

Profile

Company Names

NANOCELLECT BIOMEDICAL, INC.

Addresses

9525 TOWNE CENTRE DRIVE, #150, SAN DIEGO, CA 92121

6865 FLANDERS DRIVE, SUITE A, SAN DIEGO, CA 92121

6404 NANCY RIDGE DRIVE, SAN DIEGO, CA 92121

Phone Numbers

(858) 614-6409
951-966-4963
9519664963

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2011

State Incorporated:

DELAWARE

Total Amount Raised:

$60,578,736.00

Number of Funding Rounds:

5
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
5
2023-06-16 
$28,929,239.00 
$38,504,239.00 
$9,575,000.00 
Equity 
4
2021-08-13 
$20,000,001.00 
$20,000,001.00 
$0.00 
Equity 
3
2017-11-22 
$7,432,996.00 
$7,500,000.00 
$67,004.00 
Equity 
2
2016-08-26 
$2,466,500.00 
$3,000,000.00 
$533,500.00 
Debt 
1
2015-10-30 
$1,750,000.00 
$1,750,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
WILLIAM 
 
ALAYNICK 
EXECUTIVE OFFICER, DIRECTOR
NANOCELLECT BIOMEDICAL, INC.
JEREMY 
 
BAKER 
EXECUTIVE OFFICER
ELEANOR HOLDINGS INC.   |  NANOCELLECT BIOMEDICAL, INC.
JACK 
 
BALL 
DIRECTOR
INTELLICYT CORP   |  VIROCYT, LLC   |  REALBIO TECHNOLOGY, INC.   |  ENT BIOTECH SOLUTIONS, INC.   |  VIROCYT, INC.   |  DENOVO SCIENCES, INC.   |  NANOCELLECT BIOMEDICAL, INC.   |  AQUARO HISTOLOGY, INC.   |  CELSEE DIAGNOSTICS, INC.   |  CARTERRA, INC.   |  SWIFT BIOSCIENCES, INC.   |  CYTEK BIOSCIENCES, INC.   |  KROMATID, INC.
NICOLAS 
 
BARTHELEMY 
DIRECTOR
REPLIGEN CORP   |  908 DEVICES INC.   |  NANOCELLECT BIOMEDICAL, INC.   |  SLINGSHOT BIOSCIENCES, INC.
PAUL 
 
CONLEY 
DIRECTOR
WISPRY INC   |  LUMINUS DEVICES INC   |  NEWLANS, INC.   |  TWIST BIOSCIENCE CORP   |  SHADOW NETWORKS, INC.   |  TOMA BIOSCIENCES, INC.   |  HEALTHTELL INC.   |  MENLO MICROSYSTEMS, INC.   |  AMITREE, INC.   |  GENERAL AUTOMATION LAB TECHNOLOGIES INC.   |  PCM2 CO-INVEST LLC   |  RUBRYC THERAPEUTICS, INC.   |  TRIDENT LABS, INC.   |  SPERO DEVICES, INC.   |  1859, INC.   |  TASSO INC.   |  NORTIS INC   |  EDIFICE HEALTH, INC.   |  NANOCELLECT BIOMEDICAL, INC.   |  SWITCHBACK SYSTEMS, INC.   |  ALIDA BIOSCIENCES INC.   |  PARTILLION BIOSCIENCE CORP
NATE 
 
HEINTZMAN 
EXECUTIVE OFFICER, DIRECTOR
NANOCELLECT BIOMEDICAL, INC.
KENNETH 
 
HOOD 
DIRECTOR
NANOCELLECT BIOMEDICAL, INC.   |  BELLWETHER COFFEE CO.   |  RIGADO INC.   |  FUSIONX VENTURES FUND II, L.P.   |  FUSIONX VENTURES - BELLWETHER, LLC   |  FUSIONX VENTURES - 3DEO, LLC   |  FXVI/II - RIGADO, LLC   |  FUSIONX VENTURES - NANO3, LLC   |  FUSIONX VENTURES - NANO2, LLC   |  FUSIONX VENTURES - GENALYTE, LLC   |  FUSIONX VENTURES - BELLWETHER3, LLC   |  FUSIONX VENTURES - BELLWETHER2, LLC   |  FUSIONX VENTURES - NANO, LLC   |  FUSIONX FUND II ROLLOVER, LLC   |  FUSIONX VENTURES FUND II (QP), L.P.   |  FXVII - NUMILK LLC   |  FXVII - BELLWETHER4 LLC   |  FUSIONX VENTURES - NEURALACE, LLC   |  FXVII - BELLWETHER5, LLC   |  FUSIONX VENTURES - VITACUP LLC   |  FXVII - BLACKDOT LLC   |  FUSIONX VENTURES - NANO4, LLC   |  FUSIONX VENTURES - GENALYTE2, LLC   |  FUSIONX VENTURES - NEURALACE2, LLC   |  FXV II - 1859, LLC   |  FUSIONX VENTURES - GENALYTE3, LLC   |  FUSIONX VENTURES - VITACUP2, LLC   |  FXV II - 3DEO2, LLC   |  FUSIONX VENTURES - NEURALACE3, LLC   |  FUSIONX VENTURES - NANO5, LLC   |  FUSIONX VENTURES OPPORTUNITY FUND, L.P.   |  FXV II - 1859-2, LLC   |  FXV II - RIGADO2, LLC   |  FUSIONX VENTURES - NANO6, LLC   |  FUSIONX VENTURES - NEURALACE4, LLC   |  FXV OPPORTUNITY - 3DEO, LLC   |  FXV II - INTREPID, LLC   |  FXV II - BELLWETHER6, LLC   |  FXV II - NUMILK2, LLC   |  FXV II - NUMILK3, LLC
ALEXIS 
 
JI 
DIRECTOR
NANOCELLECT BIOMEDICAL, INC.   |  WALKING FISH THERAPEUTICS, INC.
JOS? 
 
MORACHIS 
EXECUTIVE OFFICER, DIRECTOR
NANOCELLECT BIOMEDICAL, INC.
JOSE 
 
MORACHIS 
EXECUTIVE OFFICER, DIRECTOR
NANOCELLECT BIOMEDICAL, INC.   |  PHASE TWO VENTURES FUND I, LP
CHRIS 
 
NEARY 
EXECUTIVE OFFICER, DIRECTOR
NANOCELLECT BIOMEDICAL, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2023-06-30
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2023-06-16 
2021-08-27
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-08-13 
2017-12-05
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-11-22 
2017-07-24
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2016-08-26 
2016-09-02
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2016-08-26 
2016-01-22
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-10-30 
2015-11-13
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-10-30 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#